News und Analysen

Given recent market weakness, it makes sense to start looking at buying stocks unduly sold off recently. That's why I think GE HealthCare Technologies (NASDAQ: GEHC),  Johnson Controls (NYSE: JCI),

A lot of people have the goal of being able to retire early. After all, it might seem like a great thing to be able to take control of your schedule at a time when you still have the energy to

It might seem that investors could hardly be more optimistic about Roku (NASDAQ: ROKU) stock today. After all, the streaming video specialist's shares more than doubled at one point this year and

The past couple of years have been tough, as high inflation and rising interest rates hobbled consumer and business spending alike. The tide appears to have turned in recent months, suggesting

Social Security benefits get an annual cost-of-living adjustment (COLA) to help retired workers and other recipients keep up with inflation. That aspect of the program has been critical in recent

Reality Income (NYSE: O) recently unveiled one of its largest investments in a single property. The REIT is investing $950 million in The Bellagio Las Vegas in a deal with Blackstone's non-traded

A pronounced decline in quarterly sales sent Nordstrom (NYSE: JWN) investors heading for the exits on the last trading day of the week. The storied retailer's stock price was down by almost 8% in

Shares of Premier (NASDAQ: PINC) are down 15.5% this week as of 12:05 p.m. ET Friday, according to data provided by S&P Global Market Intelligence, after the healthcare-improvement leader announced

Stock markets moved higher on Friday as comments from Fed Chair Jerome Powell briefly brought major market indexes down from their highs but didn't put a stop to the rally. Excitement about the

Stock markets moved higher on Friday as comments from Fed Chair Jerome Powell briefly brought major market indexes down from their highs but didn't put a stop to the rally. Excitement about the

Axon (NASDAQ: AXON) has grown its business on the back of tasers and body cameras, but there may be some new products and markets to fuel the next decade of growth. In this video, Travis Hoium goes

Image source: The Motley Fool.

Gap (NYSE: GPS)Q2 2023 Earnings CallAug 24, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Nordstrom (NYSE: JWN)Q2 2023 Earnings CallAug 24, 2023, 4:45 p.m. ET

Operator

Continue reading

Source Fool.com

If you're looking for a high-yield dividend stock in the healthcare sector, you might be interested in comparing Takeda Pharmaceutical (NYSE: TAK) and Viatris (NASDAQ: VTRS).

Both companies offer

If you're looking for a high-yield dividend stock in the healthcare sector, you might be interested in comparing Takeda Pharmaceutical (NYSE: TAK) and Viatris (NASDAQ: VTRS).

Both companies offer

Next-generation chipmaker Wolfspeed (NYSE: WOLF), a volatile stock even in the best of times, was having one of its better weeks on the exchange as August barreled to a close. Data compiled by S&P

Following the market's gloomy 2022, this year has been a breath of fresh air with the S&P 500 rising 14% so far in 2023. Some biotech stocks have soared even higher thanks to strong products. Cystic

Shares of connected fitness company Peloton (NASDAQ: PTON) were gutted on Wednesday following a disastrous quarterly report. Demand for its exercise bikes tumbled, subscription churn was higher than

After successfully completing multiple spaceflights in two months, Virgin Galactic Holdings, Inc. (NYSE: SPCE) has captured the attention of investors and space enthusiasts alike. The recent

It feels like an age since pandemic-related lockdowns and social restrictions were lifted. And for Peloton Interactive (NASDAQ: PTON), that marked the end of the boom in its business.

The maker of

Shares of next-gen semiconductor manufacturer Wolfspeed (NYSE: WOLF) are headed back toward multiyear lows after an ugly quarterly earnings update, one that apparently took many investors by

For a company as well-known as Airbnb (NASDAQ: ABNB), it's hard to believe that it's only been a public company for less than three years. It's also hard to believe that over that time frame

News from the Food and Drug Administration (FDA) can often make or break a stock. This month, it broke Sage Therapeutics (NASDAQ: SAGE).

Although the company obtained approval for its depression